- UroToday Home
- Beyond the Abstracts
- Urologic Oncology
Bladder Cancer
Peri-operative blood transfusion as a quality indicator of surgical care in bladder cancer: Beyond the Abstract
June 16, 2017
Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies: Beyond the Abstract
June 12, 2017
Inhibition of checkpoint kinases, an innovative strategy for treating advanced bladder cancer: Beyond the Abstract
June 11, 2017
Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer: Beyond the Abstract
May 30, 2017
KDM6A loss creates a new therapeutic targeting opportunity in bladder cancers - Beyond the Abstract
March 9, 2017
The Clonal evolution of chemotherapy-resistant urothelial carcinoma - Beyond the Abstract
March 9, 2017
Pembrolizumab therapy for chemotherapy-resistant urothelial carcinoma - Beyond the Abstract
March 9, 2017
Where are we in the salvage treatment of metastatic bladder cancer?: Beyond the Abstract
December 15, 2016
Comparative Effectiveness of a Patient Centered Pathology Report for Bladder Cancer Care: Beyond the Abstract
December 9, 2016
Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP® peptide ex vivo: Beyond the Abstract
December 5, 2016
Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer: Beyond the Abstract
November 18, 2016
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors: Beyond the Abstract
November 17, 2016
Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response: Beyond the Abstract
November 17, 2016